Theorem Clinical Research Announces Nitin Jain as Vice President and General Manager for the Asia-Pacific Region

Theorem Clinical Research Announces Nitin Jain as Vice President and General Manager for the Asia-Pacific Region
April 10, 2012

KING OF PRUSSIA, Pa.--(EON: Enhanced Online News)--Theorem Clinical Research, a full-service contract research organization (CRO) that provides core clinical research and development services, has named Nitin Jain as vice president and general manager for the Asia-Pacific region in the Singapore office.

He is responsible for developing strategies to support growth and development of the region while maximizing profitability and efficiency. Jain also oversees the Asia-Pacific client portfolio and serves as an executive client contact.

Jain previously served as the director of business development in the Asia-Pacific region for Covance. In his role, Jain was responsible for the development and business generation for Phase I-IV clinical trials. He also worked in business development roles for INC Research and in other areas in the drug development industry.

Jain received his Bachelor of Business Administration degree from AMLA in Los Angeles, Calif., and his Master of Business Administration from ACL in London, United Kingdom.

"Nitin has more than 14 years of experience on a global scale within the clinical research industry," stated Theorem Clinical Research Chief Executive Officer John Potthoff. "His expertise and knowledge of the Asia-Pacific market will be instrumental for Theorem Clinical Research as we continue to grow our presence within the region."

About Theorem Clinical Research

Theorem Clinical Research is one of the industry's leading full-service, contract research organizations (CRO). Before launching in 2011, Theorem Clinical Research operated for nearly two decades as Omnicare Clinical Research under the Omnicare Inc. parent company. A global organization with 1,000+ employees located throughout 32 countries, Theorem Clinical Research provides core CRO services for Phases I-IV, but with niche business units in the areas of technical services, medical devices and pharmaceutics with speed, flexibility and attention to detail to drive a high-quality performance. For more information, visit


Theorem Clinical Research
Shawn Clary, 484-679-2400
[email protected]